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Abstract Pantetheinase (EC 3.5.1.-) is an ubiquitous enzyme
which in vitro has been shown to recycle pantothenic acid
(vitamin B5) and to produce cysteamine, a potent anti-oxidant.
We show that the Vanin-1 gene encodes pantetheinase widely
expressed in mouse tissues: (1) a pantetheinase activity is
specifically expressed by Vanin-1 transfectants and is immuno-
depleted by specific antibodies; (2) Vanin-1 is a GPI-anchored
pantetheinase, and consequently an ectoenzyme; (3) Vanin-1 null
mice are deficient in membrane-bound pantetheinase activity in
kidney and liver; (4) in these organs, a major metabolic
consequence is the absence of detectable free cysteamine; this
demonstrates that membrane-bound pantetheinase is the main
source of cysteamine in tissues under physiological conditions.
Since the Vanin-1 molecule was previously shown to be involved
in the control of thymus reconstitution following sublethal
irradiation in vivo, this raises the possibility that Vanin/
pantetheinase might be involved in the regulation of some
immune functions maybe in the context of the response to
oxidative stress. ß 2000 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Pantetheinase (EC 3.5.1.-) catalyzes the hydrolysis of D-pan-
tetheine in the dissimilative pathway of coenzyme A (CoA)
and acyl carrier protein [1]. The hydrolytic activity is highly
speci¢c, only one of the amide bonds of pantetheine being
hydrolyzed to give cysteamine and pantothenic acid in vitro,
whereas some related compounds are not substrates [2^4].
Pantetheinase activity was found in many tissues from mam-
mals and birds [5,6] but its biological role has never been
explored in vivo. The pig kidney enzyme was puri¢ed [3,7]
and the biochemical analysis revealed its kinetic and catalytic
features [1,2], its inhibition by disul¢des [8], its thermal resis-
tance [9] and its stability versus chemical denaturation [10].
The mouse Vanin-1 has initially been characterized as a
membrane molecule expressed by a subset of thymic stromal
cells and involved in the homing of bone marrow precursor
cells into the thymus [12]. The anti-Vanin-1 407 monoclonal
antibody (mAb) injected during the reconstitution of the thy-
mus inhibits repopulation without a¡ecting cell di¡erentiation
per se. Vanin-1 is the prototypic member of a larger family
containing at least three genes in man (i.e. VNN1, VNN2,
VNN3), two in mouse (i.e. Vanin-1, Vanin-3) and one Droso-
phila homologue [13,14].
Recently, partial sequences of the pig enzyme were reported
[11] and on the basis of sequence similarities, the identity
between pantetheinase and mouse Vanin-1 has been postu-
lated.
We report here the in vitro and in vivo demonstration that
the Vanin-1 molecule is a membrane pantetheinase, which is
ubiquitously expressed in mouse tissues. Vanin-1 and pig pan-
tetheinase molecules show signi¢cant sequence similarities and
Vanin-1 transfectants gain a pantetheinase activity, which has
the same physicochemical properties as those described for pig
pantetheinase. Vanin-1 and pantetheinase are highly expressed
in the kidney where their expression is lost in Vanin-1 de¢-
cient mice. Furthermore, in vivo, the biological function of
pantetheinase deals with the recycling of pantothenic acid
(vitamin B5) and is thought to be a source of cysteamine in
tissues. Using the Vanin-1 null mice, we report here the ¢rst
experimental demonstration that directly correlates the pante-
theinase activity with the tissue level of free cysteamine, a
powerful anti-oxidant.
2. Materials and methods
2.1. Northern blot analysis and reverse transcription (RT)-polymerase
chain reaction (PCR) analysis
Total RNA was isolated from mouse tissues using the TriZol re-
agent (Gibco BRL, Life Technologies). 20 Wg of each RNA sample
was run on formaldehyde denaturing agarose gels. After transfer onto
nylon membranes (Amersham, France), hybridizations were per-
formed with probes encompassing the whole Vanin-1 cDNA sequence
as a 32P-labelled DNA probe.
1 Wg of total RNA was isolated using the TriZol reagent (Gibco
BRL, Life Technologies) from mouse tissues or sorted cell popula-
tions and reverse-transcribed with random hexamers using the Super-
script II reverse transcriptase (Gibco BRL, Life Technologies). Semi-
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quantitative PCR experiments were performed as described using ac-
tin as an internal standard [15]. Primers used in these PCR experi-
ments are: Vanin-1 forward primer: 5P-CGGTGCAGGAGAGA-
CTCAGC-3P and reverse primer: 5P-GCCAAATGAGGAAGGAC-
GTC-3P.
2.2. Vanin-1 de¢cient mice
A V phage hybridizing with a Vanin-1 probe was isolated from a
mouse 129/Ola library (kindly provided by M. Djabali). It contains a
7 kb EcoRI fragment corresponding to sequences located 2 kb up-
stream of the ATG codon and used as the 5P homology region in the
¢nal construct, a 4.5 kb EcoRI fragment encompassing proximal 5P
non-coding sequences and the ¢rst exon which was replaced by a
neomycin cassette after homologous recombination, and a 1.7 kb
EcoRI^NotI fragment containing the second exon of the Vanin-1
gene and used as the 3P homology region. The pIC19R/MC1-TK
vector [16] was modi¢ed by insertion into the SalI site of a XhoI
fragment containing the pGK-neo cassette without loxP sites: this
vector is called pIC-TK-neo. The 5P and 3P homology DNA segments
were introduced into the blunted HindIII and BamHI sites of pIC-
TK-neo, respectively. E14 (129/Ola strain) ES cells were electropo-
rated with 20 Wg of targeting vector DNA linearized at a SalI site
located at the 3P end of the construct. 24 h later, cells were selected
with 300 Wg/ml G418 and 2 WM gancyclovir. Homologous recombi-
nants were tested by hybridization of HindIII-digested genomic DNA
with an external PCR probe corresponding to the third Vanin-1 exon.
The presence of an unique integration event was checked with a neo-
mycin probe. Recombinant ES cells were injected in BALB/c blasto-
cysts, and heterozygotes were genotyped by Southern blot and PCR
using the 5P primers for neomycin 5P-CGAATTCGCCAATGACAA-
GACG-3P and endogenous sequences 5P-GTTCTCCAATCCCAA-
AGTGC-3P combined with the 3P primer 5P-ATTGATTCACCACT-
CAATCCCTG-3P. The Northern blot analysis was performed with
total kidney RNA, using a Vanin-1 cDNA probe following conven-
tional procedures.
2.3. Protein analysis
Immunohistochemistry and in situ hybridization on kidney sections
were performed as described [15].
For biochemical analysis, transfected cells were plated at 30% con-
£uence in 25 cm2 dishes and grown for 48 h. Supernatants (10^11 ml)
were collected and ultracentrifuged. Cell supernatant was either mixed
with Laemmli bu¡er or immunoprecipitated. Adherent cells were
lysed for 30 min at 4‡C in bu¡er containing 20 mM Tris, 140 mM
NaCl, 5 mM MgCl2, 0.5% NP40, 0.5% DOC and a cocktail of pro-
tease inhibitors (complete Mini, Boehringer Mannheim^Roche). Cell
lysates were harvested and the insoluble fraction removed by centri-
fugation. Immunoprecipitations from cell lysates, supernatants or
solubilized mouse kidney membrane extracts were performed using
protein G-Sepharose coupled to the rat IgG1,U anti-mouse Vanin-1
407 mAb (clone H202-407-7-4, [12]), or control IgG1 mAb. All sam-
ples were submitted to SDS^PAGE, transferred onto nylon mem-
branes, and submitted to Western blot analysis with either a rabbit
anti-Vanin-1 antiserum (AS90) prepared against an internal peptide
Vanin-1-speci¢c sequence (YAPDSPRVFHYDRKTQEGK) and re-
vealed with protein A-HRP (Pierce) and ECL (Amersham).
2.4. Bioinformatics
All Vanin sequences are accessible through EMBL database under
the following numbers: Vanin-1: AJ132098, Vanin-3: AJ132103,
VNN1: AJ132099, VNN2: AJ132100, VNN3: AJ238982, Drosophila
homologous sequence: AJ276261. Biotinidase sequence is accessible
under the following GenBank number: U03274. These sequences have
been shortened to match the known corresponding peptidic sequences
of pig pantetheinase [11]. A distance-base phylogenetic tree was gen-
erated using ClustalX (PHYLIP format) and edited using TreeView
1.5.
2.5. Enzymatic assays
The analysis of Vanin-1 enzymatic activity was performed on tissue
or cell extracts. Most enzymatic assays were performed with the
mouse thymic epithelial Vanin-1-transfected (MTE1D/VH) or paren-
tal (MTE1D) cell lines [12,17]. When indicated, cytosol and mem-
brane fractions were prepared from 80U106 cells. Membrane pellets
were solubilized in phosphate-bu¡ered saline 1% DOC.
Pantetheinase from mouse kidney and liver was extracted as pre-
viously reported for the pig enzyme [3]. Pantetheinase hydrolyzing
activity was spectrophotometrically followed (296 nm) as previously
reported [18].
One unit of enzymatic activity is de¢ned as the amount of enzyme
necessary to produce 1 Wmol of aminoethyl-cysteine ketimine in 1 min
at 30‡C.
On cell extracts, inhibition experiments were performed by treat-
ing samples for 10 min with 4,4P-dithiodipiridine (8.0 WM), pan-
tetheine (2.0 WM), iodoacetate and iodoacetamide (10.0 WM) at
pH 8.0 and activity was recorded before and after addition of mer-
captoethanol (7.0 mM). Temperature resistance was monitored re-
cording the activity of the same sample at various temperatures
(37^70‡C).
2.6. Determination of free cysteamine in tissues
Cysteamine determination in kidney and liver from wild type and
Vanin-1 de¢cient mice was performed on fresh organs immediately
homogenized in HClO4 [19] and stored at 380‡C. Crude extracts
were reduced using 10 mM mercaptopropionic acid and passed
through Dowex-1 as previously reported. Two di¡erent procedures
were used for cysteamine detection: an enzymatic assay [19] and a
high performance liquid chromatography (HPLC) detection [20]. For
the last procedure, an electrochemical detector (ESA) was used: the
potentials of oxidizing electrodes were 450 and 475 mV. The lower
detection limits were 4 nmol/g and 0.5 nmol/g for the enzymatic and
HPLC methods, respectively.
3. Results
3.1. Expression pattern of the Vanin-1 mRNAs
A previous study of the cDNA origin of expressed sequence
tag (EST) sequences has shown that Vanin-1 ESTs were found
in various libraries (heart, liver, kidney, uterus, etc.) [14]. In
Northern blot analysis (Fig. 1A), the 2.3 kb Vanin-1 tran-
script is detectable in kidney, intestine and liver. However,
when this analysis was completed by RT-PCR experiments
on a larger panel of mouse tissues, Vanin-1 transcripts were
detected in almost all organs tested in variable amounts (Fig.
1B). Furthermore, the Vanin-1 mRNAs are found in lym-
phoid organs such as thymus and spleen whereas no Vanin-
1 transcript was ever detected in circulating hematopoietic
cells. To de¢ne the cell types expressing Vanin transcripts in
kidney, an in situ hybridization experiment was performed. As
shown in Fig. 1C, epithelial cells of cortical tubules and not
glomeruli speci¢cally express Vanin-1.
3.2. The Vanin-1 molecule is a membrane-bound pantetheinase
The available pig pantetheinase peptide [11] sequences were
aligned with all known Vanin-like sequences and a phyloge-
netic tree was built using the ClustalX program. As shown in
Fig. 2, pig pantetheinase segregates with mouse and human
Vanin-1, suggesting that they are homologous genes in di¡er-
ent species. To further document Vanin-1 pantetheinase activ-
ity, the enzymatic reaction was analyzed on the Vanin-1-trans-
fected mouse epithelial cell line MTE1D/VH. As shown in
Table 1, a speci¢c activity of 2 mU/106 cells was detected
on live Vanin-1-transfected but not parental cells. After ex-
traction, the total amount of enzymatic activity could be re-
covered mainly from the DOC-solubilized membrane proteins
(22 U) and less from the cytosol (4.5 U). Furthermore, the 407
anti-Vanin-1 but not the control 106 mAb could immunode-
plete the enzymatic activity from the solubilized membrane
fraction and this activity was recovered on the mAb 407-
coated beads (Table 1). The Vanin-1 molecule contains a C-
terminus consensus sequence for coupling a GPI moiety
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(S487) anchoring it at the membrane [12]. Thus, Vanin-1 is a
membrane-bound pantetheinase.
3.3. Physicochemical properties of Vanin-1 pantetheinase
activity
Pig pantetheine hydrolyzing activity is very resistant to tem-
perature: its speci¢c activity increases with temperature up to
75‡C [9]. Mouse pantetheinase activity triples at 70‡C com-
pared to 37‡C. Pig pantetheinase activity is regulated by di-
sul¢de [8]. Pantetheine and 4,4P-dithiodipyridine reversibly in-
hibit the activity to di¡erent extents and a detailed analysis
suggested that inhibition by disul¢de involved a thiol disul¢de
exchange between those molecules and catalytic -SH group(s).
As expected, mouse pantetheinase activity is reduced by 60^
70% in the presence of pantetheine (2.0 WM) and dithiodipyr-
idine (8.0 WM), full activity was restored in the presence of
mercaptoethanol (7.0 mM). Alkylating agents, such as iodoa-
cetate and iodoacetamide, irreversibly inhibit pig pantethei-
nase by reacting with the two -SH groups essential for the
activity [21]. Similarly, mouse pantetheine hydrolyzing activity
was rapidly and irreversibly abolished by iodoacetate (10.0
WM) and iodoacetamide (10.0 WM), showing that the enzy-
matic activity depends upon thiol group(s). The pig pantethei-
nase Km for pantetheine S-pyruvate as substrate was reported
to be 28 WM at pH 8.0 and 30‡C [18]. The calculated apparent
Km for mouse Vanin-1 pantetheinase activity (16 WM) was
comparable to that calculated for pig pantetheinase added
to solubilized membrane proteins of non-transfected cells
(18 WM). Thus, the Vanin-1 and pig pantetheinase activities
are similar.
3.4. Generation of Vanin-1 de¢cient mice
A genomic clone (GV3) containing most of the promoter
Fig. 1. Tissue distribution of the Vanin-1 mRNAs. A: Northern
blot analysis: a unique 2.3 kb Vanin-1 transcript is found expressed
in mouse tissues. B: RT-PCR analysis of the Vanin-1 gene expres-
sion in a larger panel mouse tissues: PCR fragments speci¢c for Va-
nin-1 are found in all tissues tested. Ampli¢cation of a mouse actin
PCR fragment is shown as a positive control and was used to ap-
proximately standardize the amount of cDNA templates used. For
each RT-PCR experiment (+) a negative PCR control on non-re-
verse transcribed RNA (3) is shown. C: In situ hybridization detec-
tion of the epithelial cell expression of the Vanin-1 mRNA in the
cortical tubules of mouse kidney. Left panel, c: cortex; m: medulla.
Right panel, black arrow-heads indicate cortical tubule sections pre-
senting Vanin-1 positive epithelial cells (magni¢cation U8 and
U32).
Fig. 2. Phylogenetic analysis of the Vanin family of proteins. All
the partial peptide sequences of pig pantetheinase were fused to give
a polypeptide sequence of 316 amino acid residues which was
aligned with all available Vanin-like peptide sequences. A distance-
base phylogenetic tree was generated using ClustalX (PHYLIP for-
mat) and edited using TreeView 1.5. Mouse Vanin genes: Vanin-1,
Vanin-3; human Vanin genes: VNN1, VNN2, VNN3; BTD and
mu-BTD: human and mouse biotinidase gene, respectively; Dm-Va-
nin: Drosophila melanogaster Vanin-like gene.
Table 1
Determination of pantetheinase activity on Vanin-1-transfected cells




MTE1D 6 0.1 6 0.1 6 0.1
MTE1D/VH 2 mU/106 cells 22 4.5 mU/mg
MTE1D/VH+407 mAb 2 mU/106 cells 6 0.1 n.t.
MTE1D/VH+106 mAb 2 mU/106 cells 18 n.t.
Results are presented in mU/106 cells or mg protein as determined
by the Lowry method. The lower limit of detection is 0.1 mU/mg
protein. MTE1D is the parental cell line; MTE1D/VH are cells
transfected with a native form of Vanin-1. Immunodepletion was
performed using anti-Vanin-1 407 or 106 mAb-coated protein G-Se-
pharose beads (Pharmacia). n.t. : not tested. The 106 anti-JAM
mAb served as an isotype-matched control [32].
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region and the three ¢rst Vanin-1 exons was used to design
the knock-out construct. In this strategy, the ¢rst exon con-
taining the ATG initiation codon and 2 kb of 5P upstream
regulatory sequences are replaced by the neomycin gene in the
opposite transcriptional orientation preventing all possibilities
of transcription of the Vanin-1 gene (Fig. 3A). As shown by
Southern blot (Fig. 3B) and PCR analysis (Fig. 3C) on ge-
nomic DNA, the recombination event leads to the appearance
of a 4.3 kb HindIII fragment detected by an exon 3 probe and
a longer PCR fragment (350 bp) identifying the 5P junction of
the recombination. Northern blot from kidney (Fig. 3D) and
RT-PCR analysis (not shown) con¢rmed the complete ab-
sence of Vanin-1 transcript in the Vanin-1 mutant mice. The
absence of the Vanin-1 protein was con¢rmed by Western blot
and immunohistochemistry on mouse kidney (Fig. 3D,F). A
17 kDa band which is often associated to Vanin-1 immuno-
precipitates also disappeared in the null mutant, indicating
that it corresponds to a degradation product of Vanin-1. In-
terestingly, heterozygous mice showed a 50% reduction of
both Vanin-1 transcript and protein (Fig. 3D,E). The Vanin-
1 null mice develop normally and do not show any major
alteration in the maturation of lymphoid organs.
Fig. 3. Generation of Vanin-1 de¢cient mice. A: Map of the construct used for the homologous recombination. Arrows indicate the transcrip-
tional orientation of the neomycin and HSV-tk genes. Double-head arrows indicated the size of the restriction fragments obtained by Southern
blot analysis on a HindIII digest of genomic DNA from wild type or targeted alleles. The position of the 3P probe is underlined. The result of
the recombination event was checked by Southern blot (B), PCR (C) and Northern blot on kidney RNA (D). The Vanin-1 gene de¢ciency was
con¢rmed by the loss of the Vanin-1 protein in kidney visualized by Western blot (E) or immunochemistry (F). C: cortex; M: medulla; the ar-
row indicates a Vanin-1 positive cortical tubule whereas arrow-heads show Vanin-1 negative glomeruli.
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3.5. Lack of cysteamine production in tissues from Vanin-1
3/3 mice
We comparatively analyzed the enzymatic activity in organs
from wild type and Vanin-1 de¢cient mice. As expected, in
wild type animals, a mouse pantetheinase activity could be
extracted from kidney membrane fractions using butanol (Ta-
ble 2). A speci¢c activity of 8^12 mU/mg protein was ob-
served and found to be similar to that previously reported
for the pig pantetheinase [3]. Interestingly, no pantetheinase
activity was found in the kidney extracts from Vanin-1 de¢-
cient animals. In liver from wild type animals, a pantetheinase
activity was found in both the membrane (0.8 mU/mg) and
soluble (0.9 mU/mg) fractions. In Vanin-1 3/3 livers, only
the cytosolic (0.92 mU/mg) and not the membrane-bound
pantetheinase activity was detected. All these results ¢t well
with the membrane-bound distribution of the Vanin-1 mole-
cule and con¢rm its enzymatic properties in vivo.
Hydrolysis of pantetheine by pantetheinase recycles the
pantothenate moiety and produces cysteamine in vitro [2,3].
Since Vanin-1 de¢cient animals lack any detectable mem-
brane-bound pantetheinase activity in kidney and liver, we
evaluated free cysteamine levels in these organs by di¡erent
methods (Table 2). Whereas cysteamine was present in wild
type liver (24 þ 2.3 nmol/g), it was undetectable in liver from
Vanin-1 3/3 mice. Although variable results were obtained in
kidney from control mice, we were unable to detect cyste-
amine in kidney from mutant mice. This is the ¢rst evidence
that directly correlates the absence of a pantetheinase activity
to an impaired production of free cysteamine in tissues in
vivo.
4. Discussion
This report demonstrates that the Vanin-1 molecule is pan-
tetheinase. Furthermore, the Vanin-1 mutant mouse, which
develops normally, fails to produce detectable amounts of
free cysteamine, a major metabolite of pantetheinase in tis-
sues, under physiological conditions.
The Vanin molecules show signi¢cant sequence similarities
with human biotinidase (about 42% amino acid identities) but
Vanin-1 at least has no biotinidase activity. Biotinidase (EC
3.5.1.12) is an enzyme which participates in the recycling of
biotin (vitamin B8) in the body by amidohydrolyzing biocytin
[23,24]. Furthermore, Vanin molecules share with other ami-
dohydrolases a protein domain containing one cysteine and
one aspartic acid residue [14]. Mutations of the cysteine resi-
due have been reported to impair the nitrilase activity in
plants [25,26]. A recent report based on partial sequence com-
parisons between mouse Vanin-1 and pig pantetheinase has
suggested that Vanin molecules might have a pantetheinase
activity. The results presented in this report de¢nitively dem-
onstrate that Vanin-1 is pantetheinase based on two main
arguments: Vanin transfectants acquire pantetheinase activity
whereas Vanin-1 mutant mice are devoid of membrane-bound
pantetheinase activity in kidney and liver.
Vanin-1 is the prototypic member of a larger family, which
includes orthologous human and mouse Vanin genes and bio-
tinidase [14]. In human, VNN gene transcripts have a broad
tissue distribution and show partially overlapping expression
patterns. Here, we report that Vanin-1 transcripts are ubiqui-
tously expressed in mouse organs. The highest levels of Vanin-
1 mRNAs are found in kidney where the tubular epithelial
cells selectively express the Vanin-1 transcripts. This expres-
sion pattern was con¢rmed using the anti-Vanin-1 antibody,
which detected the molecule at the brush border of kidney
tubular cells, and enterocytes (not shown). Furthermore, a
recent report documented the expression of Vanin-1 tran-
scripts in developing testis [33].
In the literature, a pantetheinase activity has been found in
several tissues in both soluble and membrane-associated forms
[5,27]. The mouse Vanin-1 gene encodes a glypiated mem-
brane-bound molecule [12]. Here we show that transfection
of cells with the Vanin-1 cDNA leads to the detection of a
speci¢c pantetheinase activity in a membrane-bound form. In
vivo, Vanin-1 de¢cient mice have no detectable pantetheinase
activity in kidney and selectively lose the membrane-associ-
ated enzymatic activity in liver. These data are in complete
agreement with the expression of the Vanin-1 molecule and
strongly suggest the existence of soluble isoforms of pantethei-
nase, which might likely correspond to other Vanin family
members (i.e. Vanin-3 in mouse).
Pantetheinase hydrolyzes one of the amide bonds of pan-
tetheine recycling pantothenic acid (vitamin B5) and releasing
cysteamine. Pantothenate is present in food mostly as CoA,
which cannot be directly absorbed through enterocytes,
whereas pantothenate freely di¡uses across the epithelial bar-
rier. Thus, one might speculate that conversion of CoA into
pantothenate requires an extracellular, membrane-bound pan-
tetheinase activity capable of recycling pantothenate in gut.
Similarly, on the excretion pathway, the presence of a pante-
theinase activity at the brush border of tubular epithelial cells
might allow a salvage of vitamin B5. The other product of
pantetheinase hydrolyzing activity is cysteamine, an anti-oxi-
dant metabolite, which is one of the precursors of hypotaurine
and taurine [28]. Levels of cysteamine in vivo were reported to
range in rat liver from 7 pmol/g to 267 nmol/g tissue, demon-
strating obvious problems with published methods [20,29,30].
Furthermore, levels of cysteamine in rat liver removed imme-
Table 2
Determination of pantetheinase activity and free cysteamine in tissues from wild type and Vanin-1 de¢cient mice
Organs Genotypes Pantetheinase activity (mU/mg) Free cysteamine (nmol/g)
Membrane fractions Soluble fractions
Kidney +/+ 10 6 0.1 15
3/3 6 0.1 6 0.1 n.d.
Liver +/+ 0.8 0.9 24 +/3 2
3/3 6 0.1 0.9 n.d.
For the pantetheinase activity, results are presented in mU/mg protein and 6 0.1 represents the limit of detection of the enzymatic activity.
For the cysteamine determination, results are presented in nmol/g of fresh tissue. The results obtained on wild type kidney were variable from
mouse to mouse ranging from undetectable to physiological amounts of cysteamine. +/+: wild type animals; 3/3 : Vanin-1 null mice; n.d.:
not detectable.
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diately post-mortem or after 1 h are strongly di¡erent [20],
demonstrating that all levels reported are not unequivocally
accurate. Using two methods for cysteamine determination
from fresh tissues, we obtained comparable results showing
the absence of free cysteamine in liver and kidney from Va-
nin-1 de¢cient mice. Thus membrane-bound pantetheinase is a
main source of free cysteamine in vivo.
A recent report documents the induction of Vanin-3 gene
expression in metallothionein mutant mice, suggesting a pos-
sible link with the regulation of detoxi¢cation processes in
vivo [31]. The human VNN2/GPI-80 molecule has been found
to be involved in the migratory function of neutrophils [22],
cells that have the potential of releasing reactive oxygenated
species during in£ammatory processes. The Vanin-1 putative
function was discovered in the context of thymic reconstitu-
tion following sublethal irradiation, which generates an im-
portant source of free radicals. Preliminary results on Va-
nin-1 de¢cient mice revealed no major general or lymphoid
developmental defects under physiological conditions. The im-
portance of Vanin molecules might be revealed under stress
such as irradiation. These results suggest that the Vanin gene
family represents a novel class of ectoenzymes that might play
a more general role in the regulation of the response to oxi-
dative or in£ammatory stress.
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